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ABSTRACT
Introduction Postnatal depression (PND) affects
approximately 13% of new mothers. Community-based
activities are sought after by many mothers, especially mothers
that prefer not to access pharmacological or psychological
interventions. Singing has shown positive effects in maternal
mood and mother–child bonding. The Scaling-Up Health-Arts
Programmes: Implementation and Effectiveness Research-
Postnatal Depression study will analyse the clinical and
implementation effectiveness of 10-week singing sessions
for PND in new mothers. This protocol paper will focus on the
clinical effectiveness of this trial.
Methods and analysis A total of 400 mothers with PND (with
a score of at least 10 on the Edinburgh Postnatal Depression
Scale) and their babies will be recruited for this hybrid type II
randomised controlled trial. The intervention group will attend
10 weekly singing sessions held at community venues or
online, facilitated by the arts organisation, Breathe Arts Health
Research (Breathe). A control group will be encouraged to
attend non-singing sessions in the community or online for
10 weeks. A package of assessments will be collected from
participants for clinical, mechanistic and implementation
outcomes, at different stages of the trial. Clinical assessments
will include questionnaires and interviews for demographics,
mental health and social measures, together with biological
samples for measurement of stress markers; the study visits
are at baseline, week 6 (mid-trial) and week 10 (end of trial),
with follow ups at weeks 20 and 36. Multiple imputation will
be used to deal with possible missing data and multivariable
models will be fitted to assess differences between groups in
the outcomes of the study.
Ethics and dissemination Ethical approval has been
granted by the London-West London and GTAC Research
Ethics Committee, REC reference: 20/PR/0813.
Trial registration number NCT04834622; Pre-results.

INTRODUCTION
Postnatal depression
Postnatal depression (PND) affects approximately 13% of new mothers, with symptoms
including low mood, fatigue, anhedonia,
insomnia and irritability.1 2 Although

Strengths and limitations of this study
►► Largest cohort of participants in a study examining

singing in postnatal depression.
►► Largest cohort studying biological measures in rela-

tion to an arts intervention for postnatal depression.
►► Largest study to analyse the effect of an arts inter-

vention on the mother–infant interaction.
►► The state-of-the-art design will result in a unique

package of clinical and implementation effectiveness on this intervention.
►► There may be inconsistency throughout an intervention period if in-person sessions are switched online
due to COVID-19 social distancing restrictions.

pharmacological treatment has yielded
positive results, these are hampered by low
uptake and adherence, and while psychotherapy has produced mixed results, poses
similar challenges, including short-
lived
improvements.2–5
Prior studies have found that PND carries
implications for not only maternal health
and well-
being, but also for the mother–
infant relationship.6 A common finding is
that, while interacting with their babies,
depressed mothers spend more time in negative, withdrawn states7 8 and exhibit reduced
sensitivity,9 10 and in turn, their infants
mirror this behaviour by disengaging and
adopting a passive behavioural style.7 Moreover, depressed mothers are more likely to
report reduced feelings of attachment toward
their infant11 and are less likely to mentalise
appropriately with their newborn.12 Maternal
sensitivity is highly predictive of infant secure
attachment,13 which has long been linked to
optimal developmental outcomes including
mental health;14 thus, intervention early-on
to ameliorate the mother–infant interaction
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is warranted in order to protect offspring future development. However, while home-based interventions have
been successful in improving PND, they show limited
efficacy in helping the relationship itself.15 Indeed, a
recent combined psychoeducation and play intervention
in a community setting was found to decrease dysfunctional parenting behaviours, but the intervention proved
more effective in PND symptom reduction than in interaction improvement;16 and a very small case study found
that mother–infant painting sessions were successful in
improving both the relationship and PND symptoms,
though the sample size was only four dyads.17
Despite these challenges in finding optimal treatment
options, which can both alleviate maternal symptoms of
PND and strengthen the mother–infant relationship,
many mothers continue to engage in community group
activities, such as mother–infant play groups, as they are
found to be effective at relaxing mothers, providing good
sources of social interaction, decreasing the monotony
of each day, and providing a sense of personal fulfilment for mothers.18 Specifically, there is a growing body
of evidence demonstrating the effects of community
group singing on mental health19 20 (see also the Melodies for Mums (M4M) programme, described below).
Singing to newborns is practised around the world, and
research has demonstrated valuable benefits such as
improving mother–infant interaction and reducing infant
distress.21–23 Listening to music during pregnancy is also
associated with greater maternal well-being and reduced
symptoms of PND in the first 3 months postbirth, and,
additionally, daily singing to babies is associated with
fewer symptoms of PND and increased maternal well-
being, self-esteem and perceived mother–infant bond.24
Consequently, there is a strong theoretical background
for why singing could support mothers with PND. It is
thought that postnatally depressed women may have difficulty with adherence to dyadic interventions given the
nature and challenge of their symptoms25; however, no
prior studies have assessed whether a community singing-
based intervention may be able to both improve the
quality of the developing relationship, as well as present
as a more engaging intervention that mothers are likelier
to complete.

and tumour necrosis factor (TNF)-α, which correlated
with the observed reduction in cortisol.27 The evidence
surrounding the oxytocin system and music participation is more conflicted. Oxytocin is generally shown to
increase as a result of singing,30 31 or even listening to
music.32 However, more recent studies have demonstrated
a decrease in salivary oxytocin concentrations in certain
circumstances, for example, after choir singing, but not
solo singing.28 In addition, one study showed a decrease
in oxytocin after singing sessions, which was associated
with the increase in cytokines and reduction in cortisol,
as described above.27 This was proposed to be indicative
of a general dampening of all stress-related signalling,
in which oxytocin also plays a part, leading to an overall
improved sense of well-being.
Studies investigating the interplay of these three biological systems in relation to musical engagement during the
perinatal period are sparse. Indeed, only one study has
investigated the biological effects of maternal singing
groups,33 in which pregnant women were randomised
to either music intervention, singing intervention or
control group. This study found a decrease in cortisol in
both intervention groups, but that the effect was stronger
in the singing group. Additionally, both musical intervention groups showed an increase in salivary oxytocin
post-
session. This is of particular interest given oxytocin’s involvement in the mother–infant relationship,34
which may be strengthened in cases of mother–child
biobehavioural synchrony, in which maternal and infant
hormone levels covary.35

Biological underpinning of singing sessions for PND
Three biological pathways are suggested to underlie
the benefits of music engagement on mood: the
glucocorticoid-
modulated stress system, the inflammatory system and the oxytocin system, which is also
associated with maternal attachment and bonding. Of
these, the hypothalamic–pituitary–adrenal axis, of which
the hormone cortisol is a main measure, is the most
well studied. Studies in various populations have given
evidence for a reduction in salivary cortisol after a singing
session,26–29 pointing to a consistent stress-
reducing
effect of singing. Interestingly, one of these studies also
showed that singing sessions produced increases in the
levels of cytokines such as IL-(interleukin-)17, IL-2, IL-4

The ‘M4M’ intervention
M4M is an intervention that was developed and tested
as part of a collaboration between the Royal College
of Music, Imperial College London and University
College London (UK). M4M was tested in a three-arm
randomised controlled trial (RCT) involving 134 mothers
with PND (with an Edinburgh Postnatal Depression Scale
(EPDS) score ≥10 at baseline, indicating depression),
and compared the efficacy of community singing with
a comparison group (10 weeks of creative play classes
for dyads) and a wait-
list control group (10 weeks of
care-as-usual). This pilot study found that mothers with
moderate-
to-
severe symptoms of PND, defined as an
EPDS score of ≥13, who participated in the programme
with their baby, had a significantly faster improvement in
symptoms than mothers in usual care.36
Following the pilot study, M4M was taken-on as a service
by Breathe Arts Health Research (Breathe) across the
boroughs of Lambeth and Southwark, in South London.
However, there has since been no further research on
the programme; thus, its effectiveness on a larger scale
remains to be evaluated, as do the acceptability, appropriateness and feasibility of its delivery on a larger scale, and
its potential to be adopted and sustained as a cost-effective,
beneficial service for mothers within national health
services. In addition, there is no evidence on the effects
of M4M on mother–infant interaction, and a detailed
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mechanistic investigation of the biological underpinning
of any therapeutic effects is also missing. This paper will
focus specifically on the protocol for a Wellcome-Trust-
funded study aimed to deliver the clinical effectiveness
and the biomarkers evaluation of M4M, the ‘Scaling-Up
Health-Arts Programmes: Implementation and Effectiveness Research-
Postnatal Depression’ (SHAPER-
PND)
study. Information on the implementation effectiveness
of M4M is discussed in a separate detailed protocol.

Secondary objectives
1. To assess whether singing improves (changes) further
aspects of mental health, including depression using the Hamilton Depression Rating Scale (HDRS).
Time frame: Compare change between baseline and
weeks 6, 10, 20 and 36.

2. To assess whether singing improves (changes) further
aspects of mental health, including depression using
the Beck Depression Inventory (BDI). Time frame:
Compare change between baseline and weeks 6, 10,
20 and 36.
3. To assess whether singing improves (changes) further
aspects of mental health, including stress using the
Perceived Stress Scale (PSS). Time frame: Compare
change between baseline and weeks 6, 10, 20 and 36.
4. To assess whether singing improves (changes) further
aspects of mental health, including well-being using
the Office for National Statistics Well-
being Scale.
Time Frame: Compare change between baseline and
weeks 6, 10, 20 and 36.
5. To assess whether singing improves (changes) further
aspects of mental health, including anxiety, using
the State-Trait Anxiety Scale. Time frame: Compare
change between baseline and weeks 6, 10, 20 and 36.
6. To ascertain whether singing improves the observed
mother–infant interaction using the Crittenden
CARE-Index. Time frame: Compare change between
baseline and weeks 10 and 36.
7. To ascertain whether singing improves the perceived
mother–infant relationship using the Maternal
Postpartum Attachment Scale. Time frame: Compare
change between baseline and weeks 6, 10, 20 and 36.
8. To ascertain whether singing improves the perceived mother–infant relationship using the Parent
Reflective Functioning Questionnaire. Time frame:
Compare change between baseline and weeks 6, 10,
20 and 36.
9. To ascertain whether singing improves social support and reduces loneliness using the University of
California Los Angeles (UCLA) Loneliness Scale.
Time frame: Compare change between baseline and
weeks 6, 10, 20 and 36.
10. To ascertain whether singing improves social support
and reduces loneliness using the Multidimensional
Scale of Perceived Social Support Time frame:
Compare change between baseline and weeks 6, 10,
20 and 36.
11. To identify whether there are biological mechanisms
underpinning the psychological outcomes assessed
using changes in measurements in stress hormones,
including hair cortisol, diurnal cortisol and salivary
cytokines. Time frame: Compare change between
week 1 and weeks 6 and 10.
12. To identify whether there are biological mechanisms
underpinning the psychological outcomes assessed
using changes in measurements in salivary oxytocin.
Time frame: Compare change between week 1 and
weeks 6 and 10.
13. To identify how the singing sessions affect the lived
experience of mothers with PND using focus groups.
Time frame: Qualitative data collection at week 10
(end of intervention).
14. To explore the phenomenology of PND and how
singing intersects with PND among women with
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METHODS AND ANALYSIS
Aims
1. To determine the clinical effectiveness of the intervention in a larger sample size than previous studies
(n=400 women and their babies). This will allow us to
ascertain whether the initial findings from the pilot
study are replicable on a larger scale. To understand
whether singing is an efficacious treatment for PND,
including on mother–infant interaction, various psychological, social and qualitative measures will be collected from women and their infants before, during
and after the intervention period.
2. To ascertain the biological mechanisms by which
postnatal singing groups putatively improve maternal
mood and mother–infant relationships. This will further the current understanding of the positive effects
of the intervention and provide objectively measurable
outcomes. Maternal and infant samples will be collected to measure cortisol and oxytocin, plus maternal inflammatory markers.
Objectives and outcomes
To address our aims, we have the following objectives
and outcomes. As this protocol paper is focusing only on
the clinical effectiveness of the trial, the objectives and
outcomes of the implementation component of the trial
have been reported in a separate manuscript.37
Primary objective
1. Does community singing improve symptoms of PND?
Participants will complete the EPDS prior to the intervention (baseline) to ascertain the severity of their PND.
The EPDS will be administered again at various time
points throughout and following the intervention period
(weeks 6, 10, 20 and 36).
Outcome: The primary outcome of this study is to
understand whether singing reduces the severity of symptoms of PND on the EPDS between baseline and week 10
(end of intervention), via a reduction in total EPDS score.
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Table 1 Clinical effectiveness data collection timeline
Study
objective

Type of
measure

1

Mental
health
Mental
health

2

Measures

Time point collected

Type of data

Edinburgh Postnatal Depression Scale

Baseline, weeks 1, 6, 10,
20 and 36
Weeks 1 and 10

Quantitative

Hamilton Depression Rating Scale, Structured Clinical
Interview for DSM-IV Disorders

Quantitative

Beck Depression Inventory, State Trait Anxiety Inventory, Weeks 1, 6, 10, 20 and 36
Perceived Stress Scale; Office for National Statistics Well-
being Scale
3

Social

4

Social

5

Biological

6

Qualitative

7

Qualitative

Maternal Postpartum Attachment Scale, Parental
Reflective Functioning Questionnaire

Weeks 1, 6, 10, 20 and 36

Quantitative

Crittenden Child-Adult Relationship)*

Baseline, weeks 10 and 36

University of California Los Angeles (UCLA)
Loneliness Scale, Short General Self-Efficacy Scale,
Multidimensional Scale of Perceived Social Support

Weeks 1, 6, 10, 20 and 36

Quantitative

Diurnal cortisol saliva samples*

Baseline and week 10

Quantitative

Presession and postsession saliva samples*

Weeks 1, 6, 10 (at
sessions)

Hair samples

Week 10

Focus groups with intervention groups to capture
feedback from sessions and experiences from mothers in
the groups, focusing on the lived experience of PND
Semi-structured interviews with a sub sample of the
intervention group of women self-reporting particular
risk factors for PND (partially informed by demographic
questionnaires)

Week 10

Qualitative

Weeks 10–20, informed by Qualitative
information collected at
baseline

*Collected from mothers and infants.
PND, postnatal depression.

particular risk factors for PND (traumatic birth, adverse childhood experiences and social isolation/
loneliness) using semistructured interviews. Time
frame: Qualitative data collection at week 10 (end of
intervention).
Data collection plan
The study is anticipated to run from September 2021 to
December 2023.
In order to address the objectives within the clinical
effectiveness arm of the study, data will be collected
according to the data collection timeline in table 1.
In addition to the measures collected above, we will
also collect comprehensive information on maternal and
infant sociodemographics and medical health, maternal
history of childhood maltreatment and current maternal
abuse, in order to explore the interaction between
notable risk factors and the development of PND.

equal focus is placed on the effectiveness of the intervention and the effectiveness of its implementation.38
Study flow chart
An overview of the study timelines and procedures has
been summarised in the flowchart below (figure 1).

Trial design
SHAPER is a multidisciplinary research programme
funded by the Wellcome Trust that is hosted by King’s
College London (Sponsor) and University College
London. The SHAPER-
PND study described here is
Hybrid Type II Effectiveness-Implementation RCT, where

Setting
This is a multicentre trial that will be run in locations
across London (primarily in the South London boroughs
of Lewisham, Lambeth and Southwark), specifically in
children’s or community venues or online. These venues
will be thoroughly safety and risk assessed in light of
COVID-19 and adherence to any COVID-secure measures
will be closely monitored by Breathe.
In order to enrol a sufficiently large sample of women,
there will be 12 blocks of the 10-week singing programme
in total: 10 intervention blocks will be for the experimental group, and 2 blocks will be for women in the wait-
list control group that wish to take part in the singing
sessions. The two wait-list blocks will be offered singing
sessions after a woman has completed the first 10 weeks
of the study and no data will be collected regarding these
singing sessions, apart from the control follow-up data
that this group is expected to provide.

4
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Figure 1 SHAPER-PND study flow chart. EPDS, Edinburgh Postnatal Depression Scale; PIS, participant information sheet;
SHAPER-PND, Scaling-Up Health-Arts Programmes: Implementation and Effectiveness Research-Postnatal Depression.

In the event that one or several women need to self-
isolate due to confirmed or suspected exposure to
COVID-19, the sessions will be delivered to her/them
online via Zoom. This will allow for the sessions to still be
conducted in person with the remaining women.
In the event of the artist or the Breathe officer having
to self-isolate, a replacement Breathe-trained artist will be
ready to step-in and deliver the sessions. The same will
apply to Breathe staff; there will be another staff member
available to be present at the sessions.
Participants
Study participants will be new mothers exhibiting symptoms of PND, who meet criteria for a current major
depressive episode, and have babies aged 0–9 months.
Inclusion criteria: Women aged 18 or older; satisfactory
understanding of English; women with infants aged 0–9
months; women with PND, who score ≥10 on the EPDS.
Women will require access to an internet-
connected
device (mobile phone, tablet, computer or laptop) to
allow completion of assessments and participation in the
singing sessions in the event they go online.
Estevao C, et al. BMJ Open 2021;11:e052133. doi:10.1136/bmjopen-2021-052133

Exclusion criteria: The participant may not enter the
study if her baby is outside of the age-range specified; if
she is unable to give informed consent.
Number of participants and power analysis
The pilot RCT that informed this study showed that
depressive symptoms (EPDS scores) improved in both
singing and control women by the end of treatment
(week 10), but the singing group had a numerically
larger improvement (−5.2 (SD=2.8)) than the care-
as-
usual group (−4.25 (SD=3.2), effect size=0.32)).36 To
have power of 80% (at p<0.05, two tailed) to detect the
same effect size difference, randomising subjects 2:1, 232
subjects will be required in the intervention and 116 in
the control group (total=348). In total, 400 mothers and
their babies will be recruited to compensate for a 12%
drop-out rate.
Participants will be recruited in blocks of 40–50 women
and their babies, screened and assessed, prior to a 2:1 allocation randomisation (dyads will be allocated the same
group). This process will be repeated 10 times, aiming to
reach 400 dyads.
5
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Recruitment process
The recruitment period will last 2 years (2021–2022).
All potential participants will initially be directed to a
prescreening online form that includes an EPDS. If the
EPDS score is <10, a participant will be notified that she
is not currently eligible to participate and will be signposted to other support services within the community
(eg, talking therapies, mother–baby groups, baby activity
group). If a woman’s score is ≥10, she will be notified that
she is potentially eligible and will proceed straight to the
second phase of screening through a home (or Zoom)
visit. The participant information sheet for the trial will
be sent once the baseline assessment is booked.
When a new round of 10 classes becomes available,
researchers will arrange assessments with potential
participants to undertake the full screening interview
against the inclusion/exclusion criteria. If the participant is found non-eligible, she will be signposted to other
support services within the community.
The singing group
M4M is a 10-week intervention for mothers with PND.
The programme will be delivered to groups of 8–12
mothers in weekly sessions lasting 1 hour. Mothers will
start a block of 10-week classes together and continue
with the same group and leader for the duration of the
course. Classes are free to attend and will take place in
Children’s Centres or other community venues (or online
via Zoom). Mothers will attend with their babies and will
be invited to sit in a socially distanced circle on the floor
surrounded by soft play cushions and mats. Classes will
start with welcome songs, introducing the babies and
mothers to one another, and then involve a range of
singing and music activities. Mothers will be required to
respect social distancing guidelines and keep their babies
within their reach to avoid physical contact with other
mothers or their babies.
Some songs will be accompanied by maracas, drums,
hand chimes and other simple instruments that the
mothers and babies can play together. Instruments such
as guitar and ukulele will also be used for a small number
of songs. Instruments will not be shared between the
participants and will be disinfected before and after the
singing sessions with a COVID-19 validated disinfectant.
Mothers will also work to write some of their own
songs over the weeks, developing lyrics together about
their babies or experiences of motherhood and creating
simple melodies. Recordings of the group singing the
songs together will be made and uploaded to private
online platforms or onto CDs for the mothers to listen
to at home. Classes will be led by professional workshop
leaders trained by Breathe, with support of assistants.

in-
person or online, depending on the programmes
available at the time and government guidelines) and
will receive the same schedule of texts and phone calls
to encourage them to join these activities. They will still
be seen by the researchers to collect clinical measures
and biological samples (including the pre–post saliva
samples) and to monitor engagement in other activities.
Following the first 10 weeks, the mothers in the control
group will be offered a place on the singing programme,
but these data will not be part of the study, and they will
not join groups with other women who are in the study.
Patient and public involvement
Participants from previous sessions delivered by Breathe
in the community have provided valuable feedback and
insights into the sessions’ delivery, content and schedule.
These were gathered through focus groups and workshops
where mothers and others involved in the singing sessions
were able to share their experience of the sessions. This
body of work allowed the refinement of the sessions for
the intervention to be more suitable for the population.
A previous RCT was designed and delivered by two of
this study’s coauthors (DF and RP), along with Breathe.36
The RCT analysed the clinical efficacy of the intervention
on a smaller scale and explored the experiences of participants receiving and delivering the intervention, which
ultimately informed the design of this SHAPER-
PND
study.

The control group
The control group will be an ‘active’ control. During
the first 10 weeks (during the study period), mothers
in the control group will receive details of other non-
music classes available to them in the community (either

Data analyses
Quantitative analyses
The main statistical analyses will be carried out by the
trial statistician who will be blind to the group randomisation until the main analyses are complete. The analyses
outlined in this strategy will be primarily based on intention to treat. A per-protocol analysis will also be conducted
in which the primary outcome will also be compared
between groups, removing data of participants who:
1. Do not complete their intervention as defined above.
2. Miss over 50% of the singing or control sessions. 3. Are
later found to have an exclusion criterion that was missed.
The first stage of analyses will be a descriptive model of
the data to assess their completeness. Initially, a complete
case analysis was performed under a missing at random
assumption (MAR) where explanatory variables could
predict the missing values in the respective outcome variable. These models drop any participant who does not
provide outcome data at the follow-up time point.
Mother-level baseline variables will be described both
overall and by randomised groups. Patterns of missing
data will be described, if any. predictors of missingness
will be also assessed. The primary outcome will be analysed using linear mixed models to model the change in
total score of EPDS at 6 weeks, 10 weeks, 20 weeks and 36
weeks postrandomisation. A three-level hierarchical model
will be employed with all-time points included as repeated
measures in the model (6 weeks, 10 weeks, 20 weeks and
36 weeks postrandomisation) adjusting for baseline EPDS

6
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to improve power and take into account clustering of
the observation at mother’s level. Associations between
postrandomisation variables and missingness will be dealt
with by multiple imputation by chained equations, again
under the MAR assumption. Departures from this assumption will be assessed with a sensitivity analysis. All baseline
characteristics as well as the outcomes will be included in
the multiple imputation (MI) models. Secondary outcomes
(eg, PSS, HAM-D) will be assessed with a similar methodology for the primary outcomes, using generalised linear
mixed models depending on the type of outcome (normal,
binary and count). The questionnaires to be used have validated methods of scoring, and the scores will be analysed as
described. All analyses will be conducted in STATA V.15.1.
Qualitative analyses
Data from the focus groups will be analysed using
Thematic Analysis,39 to understand the lived experience
of PND and how this relates to experiences in the singing
group. Data from the individual/small-group interviews
with sub-groups of women self-reporting particular risk
factors for PND (traumatic birth, adverse childhood
experiences, and social isolation/loneliness) will be analysed using Interpretative Phenomenological Analysis40 to
focus in-depth on how singing intersects with the specific
context of PND among women in these sub-groups.
ETHICS AND DISSEMINATION
Ethical approval has been granted by the London-West
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